Impact of EMT in stage�IIIB/IV NSCLC treated with erlotinib and bevacizumab when compared with cisplatin, gemcitabine and bevacizumab
Villalobos, Matthias, Czapiewski, Piotr, Reinmuth, Niels, Fischer, J�rgen, Andreas, Stefan, Kortsik, Cornelius, Serke, Monika, Wolf, Martin, Neuser, Petra, Reuss, Alexander, Schnabel, Philipp, Thomas,Language:
english
Journal:
Oncology Letters
DOI:
10.3892/ol.2019.10153
Date:
March, 2019
File:
PDF, 879 KB
english, 2019